کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2568730 | 1128478 | 2014 | 13 صفحه PDF | دانلود رایگان |
• Sesquiterpene dimmer DSF-27 inhibits inflammatory mediators' production in microglia.
• Syk-dependent Akt/NF-κB pathway is important for DSF-27's anti-inflammation activity.
• Jak2/Stat3 pathway is important for DSF-27's anti-inflammation activity.
• Jak2/Stat3 signaling pathway is partly regulated by ERK and p38 MAPKs and PIAS3.
• DSF-27 protects neurons against microglia-mediated neuroinflammatory injury.
Non-receptor protein tyrosine kinases (NRPTKs)-dependent inflammatory signal transduction cascades play key roles in immunoregulation. However, drug intervention through NRPTKs-involved immunoregulation mechanism in microglia (the major immune cells of the central nervous system) has not been widely investigated. A main aim of the present study is to elucidate the contribution of two major NRPTKs (Syk and Jak2) in neuroinflammation suppression by a bioactive sesquiterpene dimmer (DSF-27). We found that LPS-stimulated BV-2 cells activated Syk and further initiated Akt/NF-κB inflammatory pathway. This Syk-dependent Akt/NF-κB inflammatory pathway can be effectively ameliorated by DSF-27. Moreover, Jak2 was activated by LPS, which was followed by transcriptional factor Stat3 activation. The Jak2/Stat3 signal was suppressed by DSF-27 through inhibition of Jak2 and Stat3 phosphorylation, promotion of Jak/Stat3 inhibitory factors PIAS3 expression, and down-regulation of ERK and p38 MAPK phosphorylation. Furthermore, DSF-27 protected cortical and mesencephalic dopaminergic neurons against neuroinflammatory injury. Taken together, our findings indicate NRPTK signaling pathways including Syk/NF-κB and Jak2/Stat3 cascades are potential anti-neuroinflammatory targets in microglia, and may also set the basis for the use of sesquiterpene dimmer as a therapeutic approach for neuroinflammation via interruption of these pathways.
Figure optionsDownload high-quality image (183 K)Download as PowerPoint slide
Journal: Toxicology and Applied Pharmacology - Volume 275, Issue 3, 15 March 2014, Pages 244–256